{"nct_id":"NCT04804605","title":"Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2021-02-25","start_date_type":"ACTUAL","primary_completion_date":"2024-05-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ARQT"]}